Rare disease families learn drug development at Ultragenyx bootcamps

cnbc.com

Ultragenyx's Rare Bootcamp offers families a guide to developing treatments for rare diseases. The program provides families with essential knowledge and resources for drug development, a complex and costly process often lacking in the rare disease space. The bootcamps, running for nine years, aim to empower patient groups to drive research and connect them with experts and other affected families.


With a significance score of 2.9, this news ranks in the top 12% of today's 28737 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Rare disease families learn drug development at Ultragenyx bootcamps | News Minimalist